Inhibition of bradykinin-induced calcium increase by phosphatase inhibitors in neuroblastoma x glioma hybrid NG108-15 cells

J Neurochem. 1997 Feb;68(2):846-54. doi: 10.1046/j.1471-4159.1997.68020846.x.

Abstract

Prior treatment of NG108-15 cells with phosphatase inhibitors including okadaic acid and calyculin A inhibited the elevation of cytosolic Ca2+ concentration ([Ca2+]i) induced by bradykinin by approximately 63%. This inhibition was dependent on the concentration of okadaic acid with an IC50 of 0.15 nM. Okadaic acid treatment only lowered the maximal response of [Ca2+]i increase and had no effect on the EC50 value for bradykinin regardless of the presence of extracellular Ca2+. Neither the capacity of 45Ca2+ accumulation within intracellular nonmitochondrial Ca2+ stores nor the magnitude of [Ca2+]i increase induced by thapsigargin was reduced by the treatment of okadaic acid. In contrast, the same phosphatase inhibitor treatment inhibited the bradykinin-evoked inositol 1,4,5-trisphosphate (IP3) generation, the Mn2+ influx, and the capacity of mitochondrial Ca2+ accumulation. Furthermore, the sensitivity of IP3 in the Ca2+ release was suppressed by okadaic acid pretreatment. Our results suggest that the reduction of bradykinin-induced [Ca2+]i rise by the promotion of protein phosphorylation was attributed to the reduced activity of phospholipase C, the decreased sensitivity to IP3, and the slowed rate of Ca2+ influx. Thus, phosphorylation plays a role in bradykinin-sensitive Ca2+ signaling cascade in NG108-15 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bradykinin / pharmacology*
  • Calcium / metabolism*
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Glioma*
  • Hybrid Cells / drug effects
  • Hybrid Cells / enzymology
  • Marine Toxins
  • Mice
  • Neuroblastoma*
  • Okadaic Acid / pharmacology
  • Oxazoles / pharmacology
  • Phosphoric Monoester Hydrolases / antagonists & inhibitors*
  • Phosphorylation
  • Signal Transduction / physiology
  • Thapsigargin / pharmacology
  • Type C Phospholipases / metabolism

Substances

  • Enzyme Inhibitors
  • Marine Toxins
  • Oxazoles
  • Okadaic Acid
  • Thapsigargin
  • calyculin A
  • Phosphoric Monoester Hydrolases
  • Type C Phospholipases
  • Bradykinin
  • Calcium